Stocks
ASND
SILVERARC CAPITAL MANAGEMENT, LLC

SILVERARC CAPITAL MANAGEMENT, LLC

CIK

1816307

City

BOSTON

State / Country

MA

Stock

ASND — Ascendis Pharma A/S

Top Portfolio Positions

65 positions · $847,049,215 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio
KALV	KalVista Pharmaceuticals, Inc. Healthcare	2,876,407	$57,902,072	6.84%
DNTH	Dianthus Therapeutics, Inc. /DE/ Healthcare	654,746	$54,946,284	6.49%
COGT	Cogent Biosciences, Inc. Healthcare	1,314,189	$50,583,134	5.97%
CELC	Celcuity Inc. Healthcare	357,903	$40,851,048	4.82%
IMNM	Immunome Inc. Healthcare	1,850,278	$40,465,579	4.78%
KOD	Kodiak Sciences Inc. Healthcare	991,930	$37,812,371	4.46%
NUVL	Nuvalent, Inc. Healthcare	354,914	$36,360,939	4.29%
ABVX	Abivax S.A. Healthcare	302,530	$33,686,715	3.98%
GLUE	Monte Rosa Therapeutics, Inc. Healthcare	2,002,040	$32,933,558	3.89%
ERAS	Erasca, Inc. Healthcare	1,851,812	$29,962,318	3.54%

Portfolio Trend

22 quarters · across all stocks

Holdings in ASND

Compact Export CSV

Shares Held

Position Value (USD)

13 of 13 shown

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$28,513,024	124,658	+153.2%	Shares	Sole	2026-05-14
2025-12-31	$10,497,378	49,228	-8.1%	Shares	Sole	2026-02-12
2025-09-30	$10,647,070	53,554	-38.1%	Shares	Sole	2025-11-12
2025-06-30	$14,938,875	86,552	+14.3%	Shares	Sole	2025-08-14
2025-03-31	$11,806,550	75,751	+47.1%	Shares	Sole	2025-05-14
2024-12-31	$7,088,765	51,491	+929.8%	Shares	Sole	2025-02-14
2024-09-30	$746,550	5,000	-78.4%	Shares	Sole	2024-11-14
2022-12-31	$2,827,431	23,151	+363.0%	Shares	Sole	2023-02-14
2022-09-30	$516,300	5,000	-80.0%	Shares	Sole	2022-10-28
2022-03-31	$2,934,000	25,000	+346.5%	Shares	Sole	2022-05-13
2021-06-30	$736,548	5,599	-70.0%	Shares	Sole	2021-08-16
2021-03-31	$2,409,282	18,694	+6.5%	Shares	Sole	2021-05-18
2020-12-31	$2,927,989	17,556	—	Shares	Sole	2021-02-16
No quarters match your search.